An Optimized Protocol for the Characterization of Zebrafish ApoB-Containing Lipoproteins Using the LipoGlo System

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Biology

Background:

• Apolipoprotein B-containing lipoproteins (ApoB-LPs) are crucial lipid transporters linked to cardiovascular disease.
• Current methods for characterizing ApoB-LPs offer limited insights into their number and size distribution.
• Mammalian models are not suitable for high-throughput drug studies on lipoproteins.

Purpose of the Study:

• To develop a novel reporter system for quantitative analysis of ApoB-LPs.
• To enable high-throughput screening of genetic and drug effects on lipoprotein metabolism.
• To overcome limitations of existing methods for ApoB-LP characterization.

Main Methods:

• Generation of a transgenic zebrafish (Danio rerio) reporter system (LipoGlo) using NanoLuc luciferase fused to ApoBb.1.
• Development of plate-based chemiluminescent assays for lipoprotein quantification.
• Implementation of gel-based assays for lipoprotein size distribution analysis and chemiluminescent microscopy for lipoprotein localization.

Main Results:

• LipoGlo provides a quantitative chemiluminescent signal proportional to the total number of ApoB-LPs.
• Optimized LipoGlo assays require 100x less starting material compared to traditional mammalian assays.
• The system allows simultaneous genotyping of zebrafish larvae for specific mutations alongside lipoprotein profiling.

Conclusions:

• LipoGlo facilitates rapid and detailed characterization of ApoB-LP molecular and cell biology.
• This reporter system enhances the study of genes and drugs impacting lipoprotein metabolism.
• LipoGlo offers a powerful, high-throughput platform for cardiovascular disease research using zebrafish models.